| |
| |
| Drug Development & Formulation is Science.
Dose Design to Create Successful Treatments is Art. |
|
|
| Achieving development milestones is critical to progressing your molecule to the clinic, but this doesn’t always translate to successful medicines or better outcomes for patients and stakeholders.
OptiDose® Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. |
|
|
| Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders. |
|
|
| |
| The Right Technologies to Address
Patient Needs, Reliably Supplied |
|
|
| Catalent’s comprehensive approach to drug development coupled with the broadest selection of advanced drug delivery technologies and manufacturing platforms available enables us to match stakeholder considerations with the right solutions. |
|
|
| Our broad range of advanced delivery technologies can address patient needs and challenges including, dose loading, taste masking, drug release, food effects and others. |
|
|
| |
| Upcoming Webinar:
Advance Your Program Through Target Product Profile Definition and Dose Design |
|
|
| Date: April 28, 2022
Time: 11:00 AM ET / 8:00 AM PT
In this exclusive webinar designed for drug developers and pharmaceutical and biotechnology consultants, Jim Spavins, former SVP of Pfizer’s industry-leading Pharmaceutical Sciences organization will discuss strategies for TPP, and Catalent’s Nathan Bennette introduces OptiDose® Design Solution, a newly integrated dose form design strategy based on the analysis of your molecule, patients, and market. |
|
|
| |
| On-Demand Webinar: Exploring Pectin and the Advancement of Delayed Release Technology |
|
|
| Watch this on-demand webinar to hear experts provide an overview of why the properties and structure of pectin are well suited for site-specific delivery to the colon. In addition, experts will also provide insights into how softgel capsules, formed by the combination of both pectin and gelatin, are used in OptiGel® DR, a new delayed release delivery technology for pharmaceutical applications. Speakers will also discuss the impact of modifying a pectin shell encapsulating a controlled release fill matrix on drug release profile and kinetics. |
|
|
| |
| |
| Every brand has a challenge. We have a solution.
|
|
|
| |
| or call +1 877 891 9609 to speak with one of our experts today!
|
|
|
